CCR9 knockout improves cardiac inflammation and fibrosis by inhibiting CCR9/CCL25 activation as well as inflammatory cytokines chemotaxis, which maintains electrical activity of cardiomyocytes and reduces the APD prolongation as well as the ion current disorder (Figure 6). Here, CCR9 is linked to inflammation.